|
|
Volumn 14, Issue 12, 2013, Pages 1471-1479
|
|
Is there still a room for azathioprine monotherapy in inflammatory bowel disease?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
IMMUNOSUPPRESSIVE AGENT;
INFLIXIMAB;
MERCAPTOPURINE;
MONOCLONAL ANTIBODY;
TUMOR NECROSIS FACTOR ALPHA;
DRUG ANTAGONISM;
DRUG COMBINATION;
ECONOMICS;
HUMAN;
INFLAMMATORY BOWEL DISEASE;
PATHOLOGY;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RECURRENT DISEASE;
REVIEW;
TREATMENT OUTCOME;
6-MERCAPTOPURINE;
ANTIBODIES, MONOCLONAL;
AZATHIOPRINE;
DRUG THERAPY, COMBINATION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INFLAMMATORY BOWEL DISEASES;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RECURRENCE;
TREATMENT OUTCOME;
TUMOR NECROSIS FACTOR-ALPHA;
MLCS;
MLOWN;
|
|
EID: 84881275401
PISSN: None
EISSN: 18735592
Source Type: Journal
DOI: 10.2174/13894501113149990172 Document Type: Review |
|
Times cited : (4)
|
|
References (0)
|
